Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical design

BackgroundSerum-containing medium (SCM), which has a number of poorly defined components with varying concentrations, hampers standardization of lymphocyte cultures. In order to develop a serum-free medium (SFM) for the expansion of human lymphocytes from peripheral blood mononuclear cells (PBMCs), a statistical optimization approach based on a fractional factorial method and a response surface method was adopted. A basal medium was prepared by supplementing RPMI1640 medium with insulin, albumin, ferric citrate, ethanolamine, fatty acids, glutamine, sodium pyruvate, 2-mercaptoethanol, 1-thioglycerol, nonessential amino acids, and vitamins. We identified additional positive determinants and their optimal concentrations for cell growth through a statistical analysis.ResultsFrom a statistical analysis using the fractional factorial method, cholesterol and polyamine supplement were identified as positive determinants for cell growth. Their optimal concentrations were determined by the response surface method. The maximum viable cell concentration in the developed SFM was enhanced by more than 1.5-fold when compared to that in RPMI1640 supplemented with 10% fetal bovine serum (FBS). Furthermore, a cytotoxicity assay and an enzyme-linked immunospot assay revealed that the effector function of cytotoxic T lymphocytes generated from PBMCs grown in SFM, by stimulation of peptide-presenting dendritic cells, was retained or even better than that in SCM.ConclusionsThe use of a developed SFM with cholesterol and polyamine supplement for human lymphocyte culture resulted in better growth without loss of cellular function when compared to SCM.

[1]  J. Romagnoli,et al.  Large‐scale expansion of cytomegalovirus‐specific cytotoxic T cells in suspension culture , 2004, Biotechnology and bioengineering.

[2]  S. Riddell,et al.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.

[3]  R. Curi,et al.  Phosphatidylcholine participates in the interaction between macrophages and lymphocytes. , 2000, American journal of physiology. Cell physiology.

[4]  D. Ponzin,et al.  Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserines containing unsaturated acyl chains. , 1992, Immunopharmacology.

[5]  S. Forman,et al.  Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. , 2006, Cytotherapy.

[6]  D. Stroncek,et al.  Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes. , 2006, Experimental hematology.

[7]  G H Sato,et al.  Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Al-Shanti,et al.  Human Purified CD8+ T Cells: Ex vivo Expansion Model to Generate a Maximum Yield of Functional Cytotoxic Cells , 2007, Immunological investigations.

[9]  J. Barrett,et al.  Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation. , 2002, Cytotherapy.

[10]  D. Powell,et al.  Adoptive T-cell therapy for malignant disorders , 2008, Haematologica.

[11]  A. Cuadrado,et al.  Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. , 1993, Oncogene.

[12]  J A Madrigal,et al.  Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. , 1999, Journal of immunology.

[13]  E. Papoutsakis,et al.  Serum‐free media for cultures of primitive and mature hematopoietic cells , 1994, Biotechnology and bioengineering.

[14]  S. Stevanović,et al.  Ex vivo generation of human cytomegalovirus‐specific cytotoxic T cells by peptide‐pulsed dendritic cells , 2001, British journal of haematology.

[15]  W. Weigle,et al.  Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha- thioglycerol , 1977, The Journal of experimental medicine.

[16]  S. Kremlev,et al.  Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. , 1994, The American journal of physiology.

[17]  J. Romagnoli,et al.  Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy. , 2003, Journal of hematotherapy & stem cell research.

[18]  W. V. van Blitterswijk,et al.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. , 1984, Journal of immunological methods.

[19]  S. Riddell,et al.  Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes , 1994, Journal of medical virology.

[20]  Jonathan C. Cohen,et al.  Dual roles for cholesterol in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Polet,et al.  Serum albumin is essential for in vitro growth of activated human lymphocytes , 1975, Journal of Experimental Medicine.

[22]  Thomas J. Bzik.  Six Sigma and Beyond: Design of Experiments , 2004, Technometrics.

[23]  X. Jin,et al.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.

[24]  J. Fung,et al.  EX VIVO GENERATION OF EFFECTIVE EPSTEIN-BARR VIRUS (EBV)-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES FROM THE PERIPHERAL BLOOD OF IMMUNOCOMPETENT EPSTEIN BARR VIRUS-SERONEGATIVE INDIVIDUALS1 , 2000, Transplantation.

[25]  B. Kearns,et al.  Application of Fractional Factorial Designs to Screen Active Factors for Antibody Production by Chinese Hamster Ovary Cells , 2006, Biotechnology progress.

[26]  D. H. Stamatis,et al.  Six Sigma and Beyond , 2001 .

[27]  J. Pieters,et al.  Essential role for cholesterol in the delivery of exogenous antigens to the MHC class I-presentation pathway. , 2006, International immunology.

[28]  J. Choi,et al.  Adoptive immunotherapy for cytomegalovirus (CMV) disease in immunocompromised patients. , 2004, Yonsei medical journal.

[29]  P. van Endert,et al.  Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection. , 2008, Journal of immunological methods.

[30]  D. Gospodarowicz,et al.  Phosphatidyl choline and the growth in serum‐free medium of vascular endothelial and smooth muscle cells, and corneal endothelial cells , 1983, Journal of cellular physiology.

[31]  A. Lohse,et al.  Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. , 1996, Journal of immunological methods.

[32]  E. W. Haeffner,et al.  Cholesterol-induced growth stimulation, cell aggregation, and membrane properties of ascites tumor cells in culture. , 1984, Cancer research.